7 research outputs found
An optimal acquisition and post-processing pipeline for hybrid IVIM-DKI in head and neck
Purpose: To optimize the diffusion-weighting b values and postprocessing pipeline for hybrid intravoxel incoherent motion diffusion kurtosis imaging in the head and neck region. Methods: Optimized diffusion-weighting b value sets ranging between 5 and 30 b values were constructed by optimizing the Cramér-Rao lower bound of the hybrid intravoxel incoherent motion diffusion kurtosis imaging model. With this model, the perfusion fraction, pseudodiffusion coefficient, diffusion coefficient, and kurtosis were estimated. Sixteen volunteers were scanned with a reference b value set and 3 repeats of the optimized sets, of which 1 with volunteers swallowing on purpose. The effects of (1) b value optim
Professional quality of life and burnout among medical physicists working in radiation oncology: The role of alexithymia and empathy
Background and purpose: The professional quality of life of radiation oncology professionals can be influenced by
different contributing factors, including personality traits. Alexithymia involves deficits in emotion processing
and awareness. Empathy is the ability to understand another’s ‘state of mind/emotion’. We investigated professional quality of life, including burnout, in radiation oncology, exploring the role of alexithymia and empathy
and targeting the population of medical physicists (MPs), since this professional category is usually underrepresented in surveys exploring professional well-being in radiation oncology and MPs may experience professional distress given the increasing complexity of multimodal cancer care.
Material and methods: An online survey was addressed to ESTRO members. Participants filled out three questionnaires to evaluate alexithymia, empathy and professional quality of life: a) Toronto Alexithymia Scale (TAS20); b) Interpersonal Reactivity Index (IRI); c) Professional Quality of Life Scale (ProQoL). Professional quality of
life as per ProQoL was considered as dependent variable. The three domains of the ProQoL, namely compassion
satisfaction (CS), secondary traumatic stress (STS) and burnout were correlated with alexithymia (as per TAS-20)
and empathy (as per IRI with three subcategories: empathic concern, perspective taking and personal distress)
and demographic/professional characteristics as independent variables. Generalized linear modeling was used.
Significant covariates on univariate linear regression analysis were included in the multivariate linear regression
model.
Results: A total of 308 medical physicists completed all questionnaires. Alexithymia as per TAS-20 was correlated to decreased CS (β = −0.25, p < 0 0.001), increased likelihood for STS (β = 0.26, p < 0 0.001) and burnout (β = 0.47, p < 0 0.001). With respect to empathy, the ‘Empatic Concern’ subscale of the IRI was found
to be a significant predictor for increased CS (β = 0.19, p = 0 0.001) and increased STS (β = 0.19, p < 0 0.001),
without significant correlation with burnout. The individual’s perception of being valued by own’s supervisor
was correlated to increased CS (β = 0.23, p < 0.001), and decreased burnout (β = −0.29, p < 0.001).
Conclusions: Alexithymic personality trait increased the likelihood to develop burnout
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood appr
Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients
Purpose: Theoretical studies have shown that dose-painting-by-numbers (DPBN) could lead to large gains in tumor control probability (TCP) compared to conventional dose distributions. However, these gains may vary considerably among patients due to (a) variations in the overall radiosensitivity of the tumor, (b) variations in the 3D distribution of intra-tumor radiosensitivity within the tumor in combination with patient anatomy, (c) uncertainties of the 3D radiosensitivity maps, (d) geometrical uncertainties, and (e) temporal changes in radiosensitivity. The goal of this study was to investigate how much of the theoretical gains of DPBN remain when a
Conducting research in Radiation Oncology remotely during the COVID-19 pandemic: Coping with isolation
Introduction: With the COVID-19 pandemic, individuals have been forced to follow strict social isolation
guidelines. While crucial to control the pandemic, isolation might have a significant impact on productivity and mental health. Especially for researchers working in healthcare, the current situation is complex. We therefore carried out a survey amongst researchers in the field of radiation oncology to gain
insights on the impact of social isolation and working from home and to guide future work.
Materials and methods: An online survey was conducted between March 27th and April 5th, 2020. The
first part contained 14 questions intended to capture an overview of the specific aspects related to
research while in isolation. The second (optional) part of the questionnaire was the validated Hospital
Anxiety and Depression Scale (HADS), a sel
Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma
Background/purpose: To determine the efficacy and toxicity profile of a stereotactic body radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous cell carcinoma (OPSCC).
Materials and methods: We performed a retrospective cohort study in 195 consecutive OPSCC
patients with T1-small T3 disease, treated at Erasmus MC between 2009 and 2016 with a SBRT
(3 5.5 Gy) boost after 46 Gy IMRT. Primary endpoints were disease-specific survival (DSS) and Grade
3 toxicity (Common Terminology Criteria). The Kaplan-Meier method and Cox regression model were
applied to determine rates and risk factors.
Results: The median follow-up was 4.3 years. Treatment compliance was high (100%). Rates of 5-year
DSS and late grade 3 toxicity were 85% and 28%, respectively. Five-year overall survival was 67%.
The most frequently observed toxicities were mucosal ulceration or soft tissue necrosis (n ¼ 30, 5 year
18%), dysphagia or weight loss (n ¼ 18, 5 year 12%) and osteoradionecrosis (n ¼ 11, 5 year 9%).
Current smoker status (hazard ratio [HR] ¼ 2.9, p ¼ .001) and Charlson Comorbidity Index 2 (HR ¼
1.9, p ¼ .03) were was associated with increased toxicity risk. Tooth extraction prior to RT was associated with increased osteoradionecrosis risk (HR ¼ 6.4, p ¼ .006).
Conclusion: We reported on outcomes in the largest patient series to date treated with a hypofractionated boost for OPSCC. Efficacy was good with survival rates comparable to conventionally fractionated (chemo)radiotherapy. Grade 3 toxicity profiles showed high rates of soft tissue necrosis and
osteoradionecrosis. Strategies to mitigate severe toxicity risks are under investigation to improve the
tolerability of the SBRT boost